Search Within

Michael John Mauro

  1. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Executive Committee, Center for Hematologic Malignancies (6)
  5. GSK Faculty (6)
  6. Hematologic Malignancies, Division of (6)

More Groups

People
  1. Martin Tallman (3)
  2. Omar Abdel-Wahab (3)
  3. Ross Levine (3)
  4. Anna Mckenney (2)
  5. Ellin Berman (2)
  6. Raajit Rampal (2)

More People

Years
  1. 2018 (5)
  2. 2015 (1)
Publications
  1. Blood (2)
  2. Cancer Research (1)
  3. Haematologica (1)
  4. Hematological Oncology (1)
  5. Leukemia Research (1)
Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Ltd (1)
  4. Ferrata Storti Foundation (1)
  5. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
    Meeting Abstract

    Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms
    Journal Article

    Mughal, T. I.; Lion, T.; Abdel-Wahab, O.; Mesa, R.; Scherber, R. M.; Perrotti, D.; Mauro, M.; Verstovsek, S.; Saglio, G.; Van Etten, R. A.; more...
    Hematological Oncology (2018)

    Fulltext@MSK | Save
  • A novel germline variant in CSF3R reduces N-glycosylation and exerts potent oncogenic effects in leukemia
    Journal Article

    Spiciarich, D. R.; Oh, S. T.; Foley, A.; Hughes, S. B.; Mauro, M. J.; Abdel-Wahab, O.; Press, R. D.; Viner, R.; Thompson, S. L.; Chen, Q.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms
    Journal Article

    Mughal, T. I.; Gotlib, J.; Mesa, R.; Koschmieder, S.; Khoury, H. J.; Cortes, J. E.; Barbui, T.; Hehlmann, R.; Mauro, M.; Saussele, S.; more...
    Leukemia Research (2018)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save